Influence of ORM1, PXR, CAR, CYP3A4 and CYP3A5 gene polymorphisms in mediating susceptibility risk to chronic myeloid leukaemia and response to imatinib mesylate therapy
Genetic polymorphisms are well recognized sources of individual differences in disease risk and treatment response. Associations between human genetic variants and predisposition to diseases and adverse events for different kinds of drug interactions with hundreds of protein like receptors, trans...
Saved in:
Main Author: | Maddin, Najlaa |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://eprints.usm.my/43138/1/Dr._Najlaa_Maddin-24_pages.pdf http://eprints.usm.my/43138/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An update on imatinib mesylate therapy in chronic myeloid leukaemia patients in a teaching hospital in Malaysia
by: Bee, P.C., et al.
Published: (2012) -
Imatinib mesylate in the treatment of chronic myeloid leukemia: a local experience
by: Bee, P.C., et al.
Published: (2006) -
Genetic determinants excluding GBCR::ABL
mutations of imatinib mesylate therapy
response among chronic myeloid
leukaemia patients in Malaysia
by: Ismail, Siti Mariam
Published: (2023) -
Influence of tert gene expression, telomerase activity and telomere length in relation to imatinib mesylate resistance in Malaysian chronic myeloid leukaemia patients
by: Shamshudin, Wati @ Hayati Mohd
Published: (2020) -
Detection of PDGFRA mutations at exons 12 and 18 among chronic myeloid leukemia patients treated with imatinib mesylate
by: Razali, Ruzi Hamimi
Published: (2015)